natgillin/translations-raw huggingface dataset:
When using pazopanib, base line and periodic monitoring of electrocardiograms and maintenance of electrolytes (e.g. calcium, magnesium, potassium) within normal range is recommended.
Kod uzimanja pazopaniba preporučuje se početno mjerenje i povremeno praćenje elektrokardiograma kao i održavanje elektrolita (npr. kalcij, magnezij, kalij) unutar raspona normalnih vrijednosti.
When using Pemetrexed medac in combination with cisplatin
Kad se Pemetrexed medac primjenjuje u kombinaciji s cisplatinom:
When using the Breelib nebuliser please follow the instructions for use provided with the device.
Kada koristite atomizator Breelib, slijedite upute za uporabu priložene uz uređaj.
When using the Breelib nebuliser please follow the instructions for use provided with the device.
Kada se koristi atomizator Breelib, potrebno je slijediti upute za uporabu priložene uz uređaj.
When using the individual correction formulae, none of the values was out of the limit.
Kad su se koristile individualizirane korekcijske formule (QTci), niti jedna vrijednost nije bila izvan granice.
When using ZACTRAN for metaphylaxis of BRD, the presence of the disease in the herd should be established first.
Pri korištenju ZACTRANa radi metafilakse BRD-a prvo je potrebno ustanoviti prisutnost bolesti u krdu.
When vardenafil (film-coated tablets) was given at doses of 5 or 10 mg on a background of stable therapy with alfuzosin, compared to placebo, there was no symptomatic reduction in blood pressure.
Kad se vardenafil (filmom obložene tablete) davao u dozama od 5 ili 10 mg uz postojeću stabilnu terapiju alfuzosinom, u usporedbi s placebom nije bilo simptomatskog sniženja krvnog tlaka.
When vardenafil (film-coated tablets) was given at doses of 5 or 10 mg on a background of stable therapy with alfuzosin, compared to placebo, there was no symptomatic reduction in blood pressure.
Kad se vardenafil (filmom obložene tablete) davao u dozama od 5 ili 10 mg uz postojeću stabilnu terapiju alfuzosinom, u usporedbi s placebom, nije bilo simptomatskog sniženja krvnog tlaka.
When vardenafil (film-coated tablets) was given at doses of 5, 10 or 20 mg on a background of stable therapy with tamsulosin, there was no symptomatic reduction in blood pressure, although 3/21 tamsulosin treated subjects exhibited transient standing systolic blood pressures of less than 85 mmHg.
Kad se vardenafil (filmom obložene tablete) davao u dozama od 5, 10 ili 20 mg uz postojeću stabilnu terapiju tamsulozinom, nije bilo simptomatskog smanjenja krvnog tlaka, premda je 3/21 ispitanika liječenih tamsulozinom pri ustajanju imalo prolazno smanjene vrijednosti sistoličkog krvnog tlaka ispod 85 mm Hg.
When vardenafil (film-coated tablets) was given at doses of 5, 10 or 20 mg on a background of stable therapy with tamsulosin, there was no symptomatic reduction in blood pressure, although 3/21 tamsulosin treated subjects exhibited transient standing systolic blood pressures of less than 85 mmHg.
Kad se vardenafil (filmom obložene tablete) davao u dozama od 5,10 ili 20 mg uz postojeću stabilnu terapiju tamsulozinom, nije bilo simptomatskog smanjenja krvnog tlaka, premda je 3/21 ispitanika liječenih tamsulozinom pri ustajanju imalo prolazno smanjene vrijednosti sistoličkog krvnog tlaka ispod 85 mm Hg.
When vardenafil 5 mg (film-coated tablets) was given simultaneously with terazosin 5 or 10 mg, one of 21 patients experienced symptomatic postural hypotension.
Kad se vardenafil 5 mg (filmom obložene tablete) davao istodobno s terazosinom od 5 ili 10 mg, jedan od 21 bolesnika razvio je simptomatsku posturalnu hipotenziju.
When Vectormune ND is given to chickens or eggs, the animals’ immune system recognises the virus as ‘foreign’ and makes antibodies against it.
Kada se cjepivo Vectormune ND da pilićima, imunosni sustav životinje prepoznaje virus kao „strano tijelo” i protiv njega proizvodi antitijela.
When VELCADE is given alone, you will receive 4 doses of VELCADE intravenously or subcutaneously on days 1, 4, 8 and 11, followed by a 10-day ‘rest period’ without treatment.
Kada se VELCADE daje sam (kao monoterapija), primit ćete 4 doze VELCADEa u venu ili potkožno 1., 4., 8. i 11. dana, nakon čega slijedi 10-dnevni ‘period odmora’ bez primjene lijeka.
When VELCADE is given in combination with other medicinal products, the Summary of Product Characteristics of these other medicinal products must be consulted prior to initiation of treatment with VELCADE.
Kada se VELCADE primjenjuje u kombinaciji s drugim lijekovima, prije započinjanja liječenja VELCADEom morate se konzultirati sa Sažetkom opisa svojstava lijeka tih lijekova.
When VELCADE is given together with dexamethasone, you will receive VELCADE intravenously as a 21-day treatment cycle and dexamethasone 20 mg is given orally on days 1, 2, 4, 5, 8, 9, 11, and 12, of the VELCADE, 21-day treatment cycle.
Kada se VELCADE daje zajedno s deksametazonom, VELCADE ćete primiti u venu u ciklusu liječenja koji traje 21 dan, a deksametazon od 20 mg uzet ćete kroz usta 1., 2., 4., 5., 8., 9., 11., i 12. dan ciklusa liječenja VELCADEom koji traje 21 dan.
When VELCADE is given together with dexamethasone, you will receive VELCADE intravenously or subcutaneously as a 21-day treatment cycle and dexamethasone 20 mg is given orally on days 1, 2, 4, 5, 8, 9, 11, and 12, of the VELCADE, 21-day treatment cycle.
Kada se VELCADE daje zajedno s deksametazonom, VELCADE ćete primiti u venu ili potkožno u ciklusu liječenja koji traje 21 dan, a deksametazon od 20 mg uzet ćete kroz usta 1., 2., 4., 5., 8., 9., 11., i 12. dan ciklusa liječenja VELCADEom koji traje 21 dan.
When VELCADE is given together with dexamethasone, you will receive VELCADE intravenously or subcutaneously as a 21-day treatment cycle and dexamethasone 40 mg is given orally on days 1, 2, 3, 4, 8, 9, 10 and 11 of the VELCADE 21-day treatment cycle.
Kada se VELCADE primjenjuje zajedno s deksametazonom, VELCADE ćete primiti u venu ili potkožno u ciklusu liječenja koji traje 21 dan, a deksametazon od 40 mg se primjenjuje kroz usta 1., 2., 3., 4., 8., 9., 10. i 11. dana ciklusa liječenja VELCADEom koji traje 21 dan.
When VELCADE is given together with pegylated liposomal doxorubicin, you will receive VELCADE intravenously as a 21-day treatment cycle and pegylated liposomal doxorubicin 30 mg/m2 is given on day 4 of the VELCADE 21-day treatment cycle as an intravenous infusion after the VELCADE injection.
Kada se VELCADE daje zajedno s pegiliranim liposomalnim doksorubicinom, VELCADE ćete primiti u venu u ciklusu liječenja koji traje 21 dan, a pegilirani liposomalni doksorubicin u dozi od 30 mg/m2 daje se kao infuzija u venu nakon injekcije VELCADEa, na 4. dan ciklusa liječenja VELCADEom koji traje 21 dan.
When VELCADE is given together with pegylated liposomal doxorubicin, you will receive VELCADE intravenously or subcutaneously as a 21-day treatment cycle and pegylated liposomal doxorubicin 30 mg/m2 is given on day 4 of the VELCADE 21-day treatment cycle as an intravenous infusion after the VELCADE injection.
Kada se VELCADE daje zajedno s pegiliranim liposomalnim doksorubicinom, VELCADE ćete primiti u venu ili potkožno u ciklusu liječenja koji traje 21 dan, a pegilirani liposomalni doksorubicin u dozi od 30 mg/m2 daje se kao infuzija u venu nakon injekcije VELCADEa, na 4. dan ciklusa liječenja VELCADEom koji traje 21 dan.
When Versican Plus DHPPi is given to dogs, the animals’ immune system recognises the viruses as ‘foreign’ and makes antibodies against them.
Kada se Versican Plus DHPPi/L4 daje psima, imunosni sustav životinje prepoznaje viruse kao „strana tijela” i proizvodi protutijela protiv njih.
When Versican Plus DHPPi/L4 is given to dogs, the animals’ immune system recognises the viruses and bacteria as ‘foreign’ and makes antibodies against them.
Kada se Versican Plus DHPPi/L4 daje psima, imunosni sustav životinje prepoznaje viruse i bakterije kao „strana tijela” i proizvodi protutijela protiv njih.
When Versican Plus DHPPi/L4R is given to dogs the animals’ immune system recognises the viruses and bacteria as ‘foreign’ and makes antibodies against them.
Kada se Versican Plus DHPPi/L4R daje psima, imunosni sustav životinje prepoznaje viruse i bakterije kao „strana tijela” i proizvodi protutijela protiv njih.
When Versican Plus L4 is given to dogs the animals’ immune system recognises the bacteria as ‘foreign’ and makes antibodies against them.
U slučaju kada se Versican Plus L4 primjenjuje u pasa, imunosni sustav životinje prepoznaje bakterije kao „strane” i proizvodi protutijela protiv virusa.
When Versican Plus Pi is given to dogs, the animals’ immune system recognises the viruses as ‘foreign’ and makes antibodies against them.
U slučaju kada se Versican Plus Pi primjenjuje u pasa, imunosni sustav životinje prepoznaje viruse i bakterije kao prepoznaju viruse kao „strane” i proizvode protutijela
When Versican Plus Pi/L4 is given to dogs the animals’ immune system recognises the viruses and bacteria as ‘foreign’ and makes antibodies against them.
U slučaju kada se Versican Plus Pi/L4 primjenjuje u pasa, imunosni sustav životinje prepoznaje viruse i bakterije kao „strane” i proizvodi protutijela protiv virusa i bakterija.
When Versican Plus Pi/L4R is given to dogs the animals’ immune system recognises the viruses and bacteria as ‘foreign’ and makes antibodies against them.
U slučaju kada se Versican Plus Pi/L4R primjenjuje u pasa, imunosni sustav životinje prepoznaje viruse i bakterije kao „strane” i proizvode protutijela protiv virusa.
When very young pigs (at 2 weeks old) have to be vaccinated, revaccination at 8-10 weeks is recommended
Kada jako mlade svinje (od 2. tjedna starosti), moraju biti cijepljene, docjepljivanje je preporučeno s 8-10 tjedana starosti.
When very young pigs (at 2 weeks old) have to be vaccinated, revaccination at 8-10 weeks is recommended.
Kada jako mlade svinje (od 2. tjedna starosti), moraju biti cijepljene, docjepljivanje je preporučeno s 8-10 tjedana starosti.
When Victoza is added to sulfonylurea therapy or basal insulin, a reduction in the dose of sulfonylurea or basal insulin should be considered to reduce the risk of hypoglycaemia (see section 4.4).
Kad se Victoza dodaje liječenju sulfonilurejom ili bazalnim inzulinom, treba razmotriti smanjenje doze sulfonilureje ili bazalnog inzulina kako bi se smanjio rizik od hipoglikemije (vidjeti dio 4.4).
When Victoza is added to treatment with a sulphonylurea or insulin, the doctor should consider lowering the dose of the other medicine to reduce the risk of having hypoglycaemia (low blood glucose).
Kada se Victoza dodaje terapiji koja sadrži sulfonilureju ili inzulin, liječnik treba razmotriti snižavanje doze drugog lijekova kako bi se smanjio rizik od hipoglikemije (niske razine glukoze u krvi).
When Viekirax was given with only dasabuvir, the virus was cleared from the blood in 91% of the patients.
Kad se Viekirax primijenio samo s dasabuvirom, virus se iščistio iz krvi 91% bolesnika.
when Viekirax with or
dasabuvirom
when Vitekta is co-administered
se Vitekta istovremeno primjenjuje
When Voriconazole Hospira treatment is stopped by your doctor you should not experience any effects.
Kada liječnik odredi prekid liječenja lijekom Vorikonazol Hospira, ne biste trebali imati nikakvih nuspojava.
When voriconazole is
primjene vorikonazola moraju se
When voriconazole is coadministered with efavirenz the dose of voriconazole should be increased to 400 mg every 12 hours and that of efavirenz should be decreased to 300 mg every 24 hours (see sections 4.2, 4.3 and 4.5).
Kada se vorikonazol primjenjuje istodobno s efavirenzom, dozu vorikonazola treba povećati na 400 mg svakih 12 sati, a dozu efavirenza smanjiti na 300 mg svaka 24 sata (vidjeti dijelove 4.2, 4.3 i 4.5).
When vortioxetine was co-administered following 6 days of ketoconazole 400 mg/day (a CYP3A4/5 and P-glycoprotein inhibitor) or following 6 days of fluconazole 200 mg/day (a CYP2C9, CYP2C19, and CYP3A4/5 inhibitor) in healthy subjects, a 1.3-fold and 1.5-fold increase, respectively, in vortioxetine AUC was observed.
Kada je vortioksetin istodobno primijenjen nakon 6 dana primjene ketokonazola 400 mg/dan (inhibitor CYP3A4/5 i P-glikoproteina) ili nakon 6 dana flukonazola 200 mg/dan (inhibitor CYP2C9, CYP2C19 i CYP3A4/5) u zdravih ispitanika, opaženo je povećanje od 1,3 odnosno 1,5 puta u AUC-u vortioksetina.
When warfarin or other oral anticoagulants are given in combination with orlistat, international normalised ratio (INR) values could be affected (see section 4.8).
Kada se varfarin ili drugi oralni antikoagulansi daju u kombinaciji s orlistatom, to može utjecati na vrijednost međunarodnog normaliziranog omjera (INR) (vidjeti 4.8).
When weak inhibitors of CYP3A4 (e.g. diltiazem) or CYP2D6 (e.g. escitalopram) are used concomitantly with this medicinal product, modest increases in plasma aripiprazole concentrations may be expected.
Kad se slabi inhibitori CYP3A4 (npr., diltiazem) ili CYP2D6 (npr., escitalopram) primjenjuju istovremeno s ovim lijekom, mogu se očekivati umjerena povećanja koncentracije aripiprazola u plazmi.
When weak inhibitors of CYP3A4 (e.g., diltiazem or escitalopram) or CYP2D6 are used concomitantly with aripiprazole, modest increases in aripiprazole concentrations might be expected.
Kad se slabi inhibitori CYP3A4 (npr., diltiazem ili escitalopram) ili CYP2D6 koriste istodobno s aripiprazolom , mogu se očekivati mala povišenja koncentracije aripiprazola.
When weak inhibitors of CYP3A4 (e.g., diltiazem or escitalopram) or CYP2D6 are used concomitantly with aripiprazole, modest increases in aripiprazole concentrations might be expected.
Kad se slabi inhibitori CYP3A4 (npr., diltiazem ili escitalopram) ili CYP2D6 koriste istodobno s aripiprazolom, mogu se očekivati mala povišenja koncentracije aripiprazola.
When weak inhibitors of CYP3A4 (e.g., diltiazem or escitalopram) or CYP2D6 are used concomitantly with aripiprazole, modest increases in aripiprazole concentrations might be expected.
Kad se slabi inhibitori CYP3A4 (npr., diltiazem ili escitalopram) ili CYP2D6 koriste istodobno s lijekom aripiprazol, mogu se očekivati mala povišenja koncentracije aripiprazola.
When weak inhibitors of CYP3A4 (e.g., diltiazem or escitalopram) or CYP2D6 are used concomitantly with aripiprazole, modest increases in aripiprazole concentrations might be expected.
Kad se slabi inhibitori CYP3A4 (npr., diltiazem ili escitalopram) ili CYP2D6 koriste istodobno s, aripiprazolom, mogu se očekivati mala povišenja koncentracije aripiprazola.
When withdrawing a cane of ampoules from the canister in the liquid nitrogen container, expose only the ampoule(s) to be used immediately.
Kod vađenja kutije sa ampulama iz kontejnera tekućeg dušika izložiti samo ampule koje će biti upotrebljene odmah.
When Xiapex was given intravenously every other day to male and female rats before cohabitation and through mating and implantation, no effects on the oestrus cycle, tubal transport, implantation and pre-implantation development and/or on libido or epididymal sperm maturation were noted with intravenous doses up to 0.13 mg/dose (approximately 11 times the human dose on a mg/m2 basis).
Kad se Xiapex intravenski davao svaki drugi dan mužjacima i ženkama štakora prije kohabitacije i tijekom parenja i implantacije, nisu bili zabilježeni nikakvi učinci na estrus, tubalni transport, implantaciju i predimplantacijski razvoj i/ili libido ili sazrijevanje sperme u pasjemeniku kod intravenskih doza do 0,13 mg/dozi (približno 11 puta veće od ljudske doze na temelju mg/m2).
When Xigduo is used with insulin, the doctor may need to lower the dose of insulin to reduce the risk of hypoglycaemia (low blood sugar levels).
Ako se lijek Xigduo koristi s inzulinom, liječnik će možda morati smanjiti dozu inzulina kako bi smanjio rizik od hipoglikemije (niskih razina šećera u krvi).
When Xultophy is added to sulphonylurea therapy, a reduction in the dose of sulphonylurea should be considered (see section 4.4).
Kada se Xultophy dodaje liječenju sulfonilurejom, treba razmotriti smanjenje doze sulfonilureje (vidjeti dio 4.4).
When Xultophy is used in patients with mild or moderate renal impairment, glucose monitoring is to be intensified and the dose adjusted on an individual basis.
Kada se Xultophy koristi u bolesnika s blagim ili umjerenim oštećenjem bubrega, treba pojačano pratiti razinu glukoze te individualno prilagoditi dozu.
When Yondelis is used in combination with PLD some of these side effects are more likely to occur and some may occur in a more severe way.
Kada se Yondelis primjenjuje u kombinaciji s PLD-om, neke od ovih nuspojava su vjerojatnije, a neke se mogu javiti u težem obliku.
When you are able to swallow, you will be given this medicine by mouth.
Čim budete mogli gutati, dobit ćete ovaj lijek kroz usta.
When you are about to take your dose of medicine, remove the protective cap by lightly squeezing the arrows marked on each side and pulling outwards (see image 1).
Neposredno prije uzimanja doze lijeka, skinite zaštitnu kapicu laganim stiskanjem strelica označenih na svakoj strani i povlačenjem prema van (pogledajte sliku 1).
When you are about to take your dose of medicine, remove the protective cap by lightly squeezing the arrows marked on each side and pulling outwards (see image 1).
Neposredno prije uzimanja doze lijeka, skinite zaštitnu kapicu laganim stiskanjem strelica označenih na svakoj strani i povlačenjem prema van (vidjeti sliku 1).
When you are being treated for HIV, it can be hard to tell whether a symptom is a side effect of Combivir or other medicines you are taking, or an effect of the HIV disease itself.
U liječenju HIV infekcije nije uvijek moguće odrediti jesu li neke nuspojave uzrokovane Combivirom, drugim istodobno primijenjenim lijekovima ili su posljedica same bolesti.
When you are being treated for HIV, it can be hard to tell whether a symptom is a side effect of Kivexa or other medicines you are taking, or an effect of the HIV disease itself.
U liječenju HIV infekcije nije uvijek moguće odrediti jesu li neke nuspojave uzrokovane lijekom Kivexa, drugim istodobno primijenjenim lijekovima ili su posljedica same bolesti.
When you are being treated for HIV, it can be hard to tell whether a symptom is a side effect of Lamivudine Teva Pharma B.V. or other medicines you are taking, or an effect of the HIV disease itself.
Ako lijek uzimate zbog infekcije HIV-om, teško je reći je li neki simptom nuspojava lijeka Lamivudin Teva Pharma B.V. ili drugih lijekova koje uzimate ili se radi o simptomu same bolesti.
When you are being treated for HIV, it can be hard to tell whether a symptom is a side effect of Ziagen or other medicines you are taking, or an effect of the HIV disease itself.
U liječenju HIV infekcije nije uvijek moguće odrediti jesu li neke nuspojave uzrokovane lijekom Ziagen, drugim istodobno primijenjenim lijekovima ili su posljedica same bolesti.
When you are given Rapiscan, your heart rate will increase quickly.
Nakon što primite Rapiscan otkucaju Vašeg srca naglo će se ubrzati.
When you are handling the tablets:
Kada rukujete tabletama:
When you are not using the pen, the cap must be replaced on the pen to protect from light.
Kada brizgalicu ne upotrebljavate, morate vratiti zatvarač na brizgalicu radi zaštite od svjetlosti.
When you are ready to give your injection prepare your pen as follows:
Kada ste spremni dati injekciju, pripremite brizgalicu kako slijedi:
When you are ready to give yourself the injection, carefully follow the steps below:
Kada ste spremni dati si injekciju, pažljivo slijedite korake navedene u nastavku:
When you are ready to inject, carefully follow the instructions in section 7 “Instructions for injecting Plegridy”, at the end of this leaflet.
Kada ste spremni za ubrizgavanje, pažljivo slijedite upute u dijelu 7 “Upute za injiciranje Plegridyja”, na kraju ove Upute o lijeku.
When you are ready to inject, hold the body of the pre-filled syringe with one hand.
Kad ste spremni dati si injekciju, jednom rukom držite tijelo napunjene štrcaljke.
When you are ready to inject, PRESS the grey start button.
Kada ste spremni na injiciranje, STISNITE sivo dugme za injiciranje.
When you are ready to inject, pull the grey needle cap straight off to avoid damaging the needle inside the pre-filled pen.
Kada ste spremni injicirati, povucite ravno sivi pokrov igle kako biste izbjegli oštećenje igle unutar napunjene brizgalice.
When you are ready to inject, twist the cap slightly to break the security seal.
Kad ste spremni dati injekciju, lagano okrenite poklopac kako bi se prekinula sigurnosna markica.
When you are ready, take your 2nd breath by repeating Step 8, using the same capsule.
Kad ste stpremni, napravite drugi udisaj ponavljajući korak 8 i koristeći istu kapsulu.
When you are sure the adapter is attached to the vial, lift off the package from the vial adapter.
Kada ste sigurni da ste pričvrstili nastavak za bočicu, maknite pakiranje s nastavka.
When you are treated with Kuvan, your doctor will test your blood to verify how much phenylalanine and tyrosine it contains and may decide to adjust the dose of Kuvan or your diet if needed.
Za vrijeme liječenja Kuvanom Vaš će liječnik tražiti pretrage krvi kako bi saznao koncentraciju fenilalanina i tirozina i kako bi, po potrebi, prilagodio dozu Kuvana ili Vašu prehranu.
When you are treated with MabThera in combination with chemotherapy, you will receive MabThera infusions on day 0 cycle 1 then day 1 of each cycle for 6 cycles in total.
Kada se liječite lijekom MabThera u kombinaciji s kemoterapijom, primit ćete infuziju lijeka MabThera nultog dana prvog ciklusa, a zatim prvog dana svakog sljedećeg ciklusa tijekom ukupno 6 ciklusa.
When you breathe in you should hear a ‘rattling’ sound as the capsule spins in the inhaler.
Tijekom udisanja trebali biste čuti ‘zvečanje’ dok se kapsula vrti u inhalatoru.
When you do this please read carefully and follow the “RebiDose Instructions for Use” provided separately in the booklet.
Kada to učinite, pozorno pročitajte „Upute za upotrebu uređaja RebiDose“ koje se nalaze zasebno u brošuri te ih se pridržavajte.
When you do this you may see insulin come out of the needle.
Dok to radite, možda ćete vidjeti da inzulin istječe iz igle.
When you do this, if you accidentally push liquid back into the vial, slowly pull the plunger to draw the liquid back into the syringe.
Kad to učinite, ako slučajno istisnete dio otopine natrag u bočicu, polako povucite klip kako biste je uvukli natrag u štrcaljku.
When you fill a new reservoir, be certain not to leave large air bubbles in either the syringe or the tubing.
Kad punite novi spremnik, provjerite da u štrcaljki i kateteru nisu ostali veći mjehurići zraka.
When you first receive this medicine and during the course of the treatment, also between doses, tell your doctor or nurse immediately if you:
Kada prvi put primite ovaj lijek te za trajanja liječenja, također i između doza, odmah obavijestite svog liječnika ili medicinsku sestru ako:
When you first start taking Otezla, you will receive a ‘treatment initiation pack’ which contains all the doses as listed in the table below.
Kada počnete uzimati lijek Otezla, dobit ćete pakiranje za početak liječenja koje sadrži sve doze kako je navedeno u tablici ispod.
When you first start using Instanyl, your doctor will work with you to find the dose that will relieve your breakthrough pain.
Kad započinjete liječenje Instanylom, liječnik će u suradnji s Vama pronaći optimalnu dozu za olakšavanje probojne boli.
When you first start using these medicines together, your doctor may tell you to lower the dose of the sulfonylurea medicine.
Kad prvi puta započnete ove lijekove uzimati zajedno, liječnik Vam može reći da smanjite dozu sulfonilureje.
When you first use the nasal spray you will need to shake it vigorously with the cap on for about 10 seconds.
Kada prvi put koristite sprej za nos, morate ga snažno protresti sa zatvaračem oko 10 sekundi.
When you get the desired response, you will be given hCG or r-hCG.
Kada postignete željeni odgovor, dobit ćete hCG ili r-hCG.
When you get the desired response, you will be given hCG or “recombinant hCG” (r-hCG, an hCG made in a laboratory by a special DNA technique).
Kad dobijete željeni odgovor, dat će Vam se hCG ili „rekombinantni hCG“ (r-hCG, to je hCG napravljen u laboratoriju pomoću posebne DNK tehnike).